Daniel Groman's most recent trade in Walker & Dunlop Inc was a trade of 38 Dividend Equivalent Rights done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretrary & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 38 | 96 | - | - | Dividend Equivalent Rights | |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 3,594 | 17,359 (0%) | 0% | 0 | Common Stock | |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 2,325 | 0 | - | - | Deferred Stock Units | |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.19 per share. | 14 Mar 2025 | 1,665 | 15,694 (0%) | 0% | 87.2 | 145,171 | Common Stock |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 1,162 | 0 | - | - | Restricted Stock Units | |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 107 | 57 | - | - | Dividend Equivalent Rights | |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 39 | 165 | - | - | Dividend Equivalent Rights | |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 5,784 | 5,784 | - | - | Deferred Stock Units | |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 4,627 | 14,754 (0%) | 0% | 0 | Common Stock | |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 2,892 | 2,892 | - | - | Restricted Stock Units | |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretary and CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.44 per share. | 14 Feb 2025 | 990 | 13,764 (0%) | 0% | 86.4 | 85,576 | Common Stock |
| Walker Dunlop Inc | Daniel J. Groman | EVP, GC, Secretrary & CCO | 06 Dec 2024 | 13 | 125 | - | - | Dividend Equivalent Rights | ||
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.97 per share. | 14 Nov 2023 | 5,000 | 133,828 | - | 10.0 | 49,850 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.09 per share. | 17 Oct 2023 | 5,000 | 138,828 | - | 9.1 | 45,450 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.07 per share. | 19 Sep 2023 | 5,000 | 143,828 | - | 9.1 | 45,350 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 31,444 | 150,862 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 19,223 | 156,893 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.94 per share. | 16 Aug 2023 | 13,192 | 137,670 | - | 7.9 | 104,744 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.18 per share. | 16 Aug 2023 | 8,065 | 148,828 | - | 8.2 | 65,972 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 4,045 | 121,178 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 7.89 per share. | 11 Aug 2023 | 1,760 | 119,418 | - | 7.9 | 13,886 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 4,451 | 118,983 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.10 per share. | 10 Aug 2023 | 1,850 | 117,133 | - | 8.1 | 14,985 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 4,855 | 116,638 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.08 per share. | 09 Aug 2023 | 2,106 | 114,532 | - | 8.1 | 17,016 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2023 | 5,259 | 114,100 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.32 per share. | 08 Aug 2023 | 2,317 | 111,783 | - | 8.3 | 19,277 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 17 Jul 2023 | 3,877 | 108,841 | - | 11.3 | 43,849 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.86 per share. | 20 Jun 2023 | 3,877 | 112,718 | - | 8.9 | 34,350 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 44,260 | 136,100 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.87 per share. | 15 Jun 2023 | 18,568 | 117,532 | - | 8.9 | 164,698 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.87 per share. | 15 Jun 2023 | 937 | 116,595 | - | 8.9 | 8,311 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 113,538 | 139,470 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.93 per share. | 24 May 2023 | 47,630 | 91,840 | - | 7.9 | 377,706 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 7.91 per share. | 22 May 2023 | 50,000 | 25,932 | - | 7.9 | 395,500 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 22 May 2023 | 3,877 | 75,932 | - | 8 | 31,016 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.34 per share. | 10 May 2023 | 15,048 | 79,809 | - | 8.3 | 125,500 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 21,974 | 104,076 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 25 Apr 2023 | 9,219 | 94,857 | - | 8.3 | 76,794 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.66 per share. | 17 Apr 2023 | 3,877 | 82,102 | - | 9.7 | 37,452 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.94 per share. | 17 Mar 2023 | 3,877 | 85,979 | - | 10.9 | 42,414 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.93 per share. | 17 Feb 2023 | 3,877 | 89,856 | - | 10.9 | 42,376 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 21,976 | 102,952 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.88 per share. | 25 Jan 2023 | 9,219 | 93,733 | - | 11.9 | 109,522 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.93 per share. | 17 Jan 2023 | 3,877 | 80,976 | - | 10.9 | 42,376 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.26 per share. | 10 Jan 2023 | 32,190 | 84,853 | - | 11.3 | 362,459 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 9,343 | 9,343 | - | - | Stock Option (Right to Buy) | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 5,651 | 117,043 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 13.69 per share. | 14 Nov 2022 | 7,000 | 116,495 | - | 13.7 | 95,830 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 14.06 per share. | 14 Nov 2022 | 5,103 | 111,392 | - | 14.1 | 71,748 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 21,976 | 129,418 | - | 0 | Class A Common Stock | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.30 per share. | 25 Oct 2022 | 5,923 | 123,495 | - | 13.3 | 78,776 | Class A Common Stock |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Enfusion Inc Ordinary Shares | Daniel Groman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 6,339 | 107,442 | - | 0 | Class A Common Stock |